Axogen Inc vs GameStop Corp. — how do they compare? Axogen Inc trades at $39.4 (market cap $2.06B), while GameStop Corp. trades at $22.49 (market cap $10.06B). The key difference: GameStop Corp. is far larger — about 4.9× Axogen Inc's market cap, and Axogen Inc is trading nearer its 52-week high, GameStop Corp. nearer its low. Which is the better fit depends on your goals.
| AXGN | GME | |
|---|---|---|
Market Cap | $2.06B | $10.06B |
Sector | Technology | Consumer Cyclical |
52-Week High | $46.19 | $27.69 |
52-Week Low | $11.28 | $19.94 |
Enterprise Value | $1.98B | $6.04B |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
GME trades at $22.03, up 1.61% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.30 exceeding the $0.16 estimate. Revenue for 2025 was $3.82 billion, with net income of $131.3 million and a profit margin of 3.43%. Recent news highlights the proposed eBay acquisition and a robust EBITDA outlook exceeding $600 million for fiscal 2026.
The outlook is mixed; fundamental improvements in profitability and strategic moves like the eBay bid offer potential upside, but bearish technicals and a majority hold rating from analysts suggest caution. Key risks include execution of the acquisition, competitive pressures from digital game distribution, and reliance on collectibles growth.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →